BiochemOki

3 ms·

1. 1.▲
   by BiochemOki 7y ago

   Yes, we are looking at IV, as others have done already clinically. We aren't looking at aptamers or other clever ways of binding small toxic biomolecules. I hope that other groups are!
2. 2.▲
   by BiochemOki 7y ago

   Great question. Two problems with making a therapeutic antibody against seven KC. One is that we are not sure how good the seven KC antibodies are yet. We are working on this. The problem there is that 7KC only differs from cholesterol by o
3. 3.▲
   by BiochemOki 7y ago

   Hi, I'm co-founder of Underdog and the scientist who invented the drugs we are developing. Cool that this community has taken an interest. I agree with a lot of the insightful comments here. If you're interested in diving deeper i